BPAF Consortium Use description (ExposureBased waiving).

Annex I - List of acronyms and abbreviations Acronym AC B CAS CF2 CF3 CfE CF3C(O)F CFF CLP CO2 COC COP CSR CTFE DNEL EC ECHA EEA EEAP EFCTC EFSA EINECS ELV EMA EPA ETF EU EV EVOH F-Gas FCM FP GLP GWP HCFC HCFO-1233zd(E) HF HFC HFC-125 HFC-134a HFC-143a HFC-227ea HFC-236fa HFC-245fa HFC-32 Explanation Airconditioning Bioaccumulation Chemical Abstracts Service Methylene Fully fluorinated methyl Call for Evidence Trifluoroacetyl Fluoride Cold Form Foils Classification, Labelling and Packaging Carbon dioxide Cyclic olefin copolymer Cyclic olefin polymer Chemical Safety Report Chlorotrifluoroethylene Derived No-Effect Level European Commission European Chemicals Agency European Economic Area Environmental Effects Assessment Panel European Fluorocarbons Technical Committee European Food Safety Authority European Inventory of Existing Chemical Substances End of Life of Vehicles Directive European Medicines Agency Environmental Protection Agency Extrudable thermoplastics films European Union Electric Vehicle Ethylene vinyl alcohol Fluorinated Gas Food Contact Materials rules Fluorinated Products Good Laboratory Practice Global Warming Potential Hydrochlorofluorocarbon (1E)-1-chloro-3,3,3-trifluoroprop-1-ene Hydrogen Fluoride Hydrofluorocarbon Pentafluoroethane 1,1,1,2-tetrafluoroethane 1,1,1-trifluoroethane 1,1,1,2,3,3,3-heptafluoropropane 1,1,1,3,3,3-hexafluoropropane 1,1,1,3,3-pentafluoropropane Difluoromethane 1 HFC-365mfc HFO HFO-1233zd HCFO-1233zd(E) HFO-1234yf HFO-1234ze(E) HFO-1336mzz(E) HFO-1336mzz(Z) Honeywell HSE IUPAC IVD IVDR LRTP MAC MDI MDR Mln MoE NOAEL NOEC OECD OTC P PBT PCTFE PET PFAS PFC PFOA PFOS PLC PNDT PNEC PP PTFE Proposal PVC PVDC RAC RAAF R&D REACH RHVAC RMM RMOA RO RRM SAP SEAC 1,1,1,3,3-pentafluorobutane Hydrofluoroolefin (1E)-1-chloro-3,3,3-trifluoroprop-1-ene Trans 1-Chloro-3,3,3-trifluoroprop-1-ene 2,3,3,3- tetrafluoroprop-1-ene Trans-1,3,3,3-tetrafluoroprop-1-ene Trans-1,1,1,4,4,4-hexafluorobut-2-ene (2Z)-1,1,1,4,4,4-hexafluorobut-2-ene Honeywell International Inc.

best regards, Dit bericht kan informatie bevatten die niet voor u is bestemd.

dd Dec 20 WP WP0 DE/NL Responsible WP1 DE/NL Activities Coordination Preparation of Call for Evidence (including questionnaire and information document) in agreement between MS Call for Evidence (all MS and ECHA with news alerts and websites of all MS with Link to Helpdesk webpage) Preparation of Restriction option analysis document (all MS) RIME+ Dortmund 1st draft of restriction option analysis document (all MS) 2nd draft of restriction option analysis document (all MS) Finalisation of document, i.e. clarification of restriction options and scope (all MS) Restriction option analysis document to be uploaded on CIRCA (DE/ NL CA) RMOA-Conclusion, PACT-Update WP2 Drafting discussion paper NL Wordt vragenlijst + aanvulling 1e discussion paper WP3 DE/DK DE/DK WP4 NL/DE Verwerken commentaren van NO, SE, DE, I&W en RIVM deskundigen Coordination and alignment Pre-phase for environmental and human health hazard assessment --> Overview of relevant hazards (besides persistence) and generation of draft lists of substances for assessment Assessment phase --> Draft text for restriction proposal WP5 NO WP6 SE/DE Overview analytical methods (ch E7) Overview human and environmental monitoring data Working plan Design template for collection of monitoring date Presentation of slide WP6 at RiME Meeting wieh NCSU Collect monitoring data - ENV Collect monitoring data - HUM RiME FEB-2021 WP7 Scoping essential use NL Scoping impact assessment Baseline and restriction scenario(s) Economic impact assessment Environmental impact assessment Health impact assessment Assessment of other impacts Proportionality analysis Monthly meetings starts 2nd version questionnaire Draft of information document (DE/NL CA) Commenting round (all MS) Revision and draft of 3rd version of questionnaire and information document for WebEx (DE/NL CA) Detailed discussion of questionnaire and information document (all MS) Webex Final version (DE/ NL CA) Notification into PACT (DE/ NL CA) Discussion of responses received so far, data (all MS) Webex Decision on meetings with industry (all MS) DDiescciusisosnioonnowf rheiscthrircetisotrnicstcioonpeopantidonospstihoonusld(ablleMpSre) sWenetbeedx and discussed in RiME+ (all MS) Meetings with stakeholders and industry Presentation on RMOA for RiME May 2020 Contributions of first drafts of document parts according to lead in work packages and sub-work packages (all MS) Merge of contributions, redrafting (DE/ NL CA) Redrafting by all MS Merge of contributions, redrafting (DE/ NL CA) 31-Mar-20 4-May-20 August/September 2020 20/21 October 2020 25-Sep-20 5-Oct-20 19-Oct-20 Last redrafting by all MS Finalisation (DE/ NL CA) Commenting (by all other MS not part of group) Consideration of comments/if needed redrafting of document (DE/ NL CA in agreement with group) Webex meeting for initial discussing based on broad definition (NL, DE, SE, DK, NO, ECHA, COM) 1st discussion paper prepared by NL Face-to-face meeting (NL, DE, SE, DK, NO, ECHA, COM) based on discussion paper 2nd discussion paper prepared by NL (before RiME+) 26-Oct-20 10-Nov-20 23 - 27 November 2020 1-Dec-20 4-Jan-21 Discussion during RiME+ meeting Final discussion paper prepared by NL 2021 - TO BE PREPARED Kick-off meeting Joint HH/ENV progress meetings HH subgroup meetings ENV subgroup meetings Start up, Develop generic information basis for all sub-uses, structure of the sub-use reports (by WP7) - DONE Kick-off meeting (Discussion of content of each sub-use to avoid overlaps and discussion of revision of list of sub-uses and discussion of ETH Zrich work) - DONE 1 May 2020 1 Nov. 2020 Start up sub uses, Project plan fine tuning for sub-uses (and if needed tendering for consultants) Progress meeting after CfE is closed to check sub-uses, decide on stakeholder meetings (i.e. via mail) Stakeholder Meetings per sub-use: Follow up on information from CfE and to address knowledge gaps Sub-use studies (including gap analysis) Progress meeting Progress meeting Final reports consultants (& feedback to WP2) Integration of information (including gap analysis) Additional studies (i.e. membranes, processing aids?)

Claigan Environmental Inc. 10 Brewer Hunt Way, Suite 200 Kanata, ON, Canada, K2K 2B5 Claigan PFAS Submission #5 PFAS Derogations and Justifications Derogations needed for PFAS applications necessary for society without effective substitutes Document is UNCONTROLLED if printed.

Pilot-Scale Fluoropolymer Incineration Study: Thermal Treatment of a Mixture of Fluoropolymers under Representative European Municipal Waste Combustor Conditions Dr.

= ISN= a= > I'IT =) LS C I oe (80 ) QAI B = PAE || i4ii : 6.18 MPa 0.59 MPa m 2. 4 J f O 1 O 0 9 0 ^ l b 76 J 4 3 tJ LI.

LIFE SAFETY DISTRIBUTION GmbH Z.A.

Attachment: Section It Non-confidental comments Onitem 6): a SSuubbssttaannccee PFIVFDEF >501.27ttoonnssppaa. 6. + True sir microwave level messuring sensor + GlWiadtienrgrpeesirsftoarnmcaen,cvee,ryesoswfiwcattieorn,albosowrapbtriaosnion ++ oRaidsieacttiroinc creosnissttaanntce + Chemicalresistance ++ FTleammpeer/atbuurren rcheasriascttaenrciestaitcshigh an low temperature + OVradiation resistance n%3 + Matera strength even at very high and ow tampertures : + Guidedmiatcestrvceolonmeaswnsuraingvsenseor : ++ TCehmepmeircaatlurreseisretsainscteance t igh and low temperature

= Pm Cw EE Seeruny ---- =) eeent c Ee ge e] ] ein.

"Coming together is a beginning, working together is a success."

EDRA Comments for Annex XV restriction report Our sector views the possible wide impact of the restriction as leading to a situation where there are no alternatives available in many product areas, with consequent difficulties to purchase and sell some of the product groups.

Klikk her for a delta i motet Bli med pa en videokonferanseenhet _@ vc.miljodir.no Videokonferanse-ID: 128 997 897 6 Alternative VTC-instruksjoner Finn ut mer I Motealternativer 3